Rezolute, Inc. (RZLT) stock
RZLTNasdaqPharmaceutical PreparationsFiscal year ends June 30
$4.25+0.24 (+5.85%)
Close on Nov 18, 2026Market cap $411.07MP/E –Yield –
Rezolute price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for Rezolute
Rezolute has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?